Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BB Biotech AGXSWX:BION +1.17%33 3-Year Book Growth Rate is 1.00% as of Jun. 2026, which is 11% above its 10-year median of 0.90. GuruFocus rates XSWX:BION with a GF Score™ of 33/100. The stock has 3 warning signs investors should review. Among 1,131 Biotechnology companies, BB Biotech AG ranks better than 64.46% on this metric.
During the past 12 months, BB Biotech AG's average Book Value per Share Growth Rate was 65.80% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 1.00% per year.
During the past 5 years, the average Book Value per Share Growth Rate was -7.80% per year.
During the past 10 years, the average Book Value per Share Growth Rate was -3.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of BB Biotech AG was 38.00% per year. The lowest was -27.40% per year. And the median was 0.90% per year.
BB Biotech AG (XSWX:BION) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
BB Biotech AG 3-Year Book Growth Rate Related Terms
XSWX:BION vs VRTX, REGN, RVMD: 3-Year Book Growth Rate Comparison
For the Biotechnology subindustry, BB Biotech AG's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BB Biotech AG 3-Year Book Growth Rate vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, BB Biotech AG's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where BB Biotech AG's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 1.00% mean?
BB Biotech AG (XSWX:BION) has a 3-Year Book Growth Rate of 1.00% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for BB Biotech AG and its competitors. This is 11% above median its historical median of 0.90. According to the industry distribution chart, BB Biotech AG ranks #402 out of 1131 companies in the Biotechnology industry, placing it in the top 35.5%.
Is BB Biotech AG's 3-Year Book Growth Rate too high?
BB Biotech AG's current 3-Year Book Growth Rate of 1.00% is 11% above median its 10-year median of 0.90. Based on the distribution chart, BB Biotech AG ranks #402 out of 1131 companies in the Biotechnology industry, which is above the industry midpoint. Overall, BB Biotech AG has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does BB Biotech AG's 3-Year Book Growth Rate compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, BB Biotech AG ranks #402 out of 1131 companies for 3-Year Book Growth Rate. This puts BB Biotech AG in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Biotechnology company?
A good 3-Year Book Growth Rate depends on the Biotechnology industry context. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for BB Biotech AG and its competitors. BB Biotech AG's current 3-Year Book Growth Rate is 1.00%, which is 11% above median its own 10-year median of 0.90. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BB Biotech AG stock overvalued right now?
BB Biotech AG (XSWX:BION) has a current 3-Year Book Growth Rate of 1.00%. The current 3-Year Book Growth Rate is 1.00%, which is 11% above median its 10-year median of 0.90. BB Biotech AG's overall GF Score™ is 33/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For BB Biotech AG (XSWX:BION), the current 3-Year Book Growth Rate is 1.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market, and is one of the investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. Geographically company operates in the USA, Netherlands, Singapore, Great Britain, Canada, Switzerland, Curacao, and British Virgin Island.
33GF Score
Get the complete analysis for XSWX:BION
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:BION has been successfully added to your 
